BioProcess International Europe is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Dr. Krishna Prasad, the founder of Citranvi™, is a recognized industry leader in Vaccine Development. Prior to this, Dr. Prasad functioned as the Director of Vaccine Research and Development, at Pfizer. He spent 20 years at Wyeth/Pfizer, he successfully led many innovative and complex multi-component vaccine candidates through all stages of pre-clinical and clinical development through commercial licensure. This includes Pneumococcal conjugate vaccine Prevnar-13® and many clinical candidates. He has been named as an inventor or co-inventor in more than 150 granted patents, world-wide, which played a significant role towards the development and protection of Pfizer’s diverse conjugate vaccine intellectual property portfolio.